This web-based tool developed at RAS Initiative at Frederick National Lab for Cancer Research, namely RAS Pathway DepMap Correlation Network Explorer, is intended to help study and infer the potential context-dependent gene-gene relations on top of correlation networks derived from DepMap genome-wide CRISPR screening data (DepMap Portal), which was originally created by DepMap Consortium (DMC) and hosted by BROAD Institute, and primarily focus on the context of RAS signaling with derived context-dependent functional modules, GPMTC (Good Paired Mutual Top Correlated) genes, as well as gene-gene correlation relations.
Below we briefly introduce the main features of the tool, which visualizes, manipulates, and analyzes the RAS-pathway focused and genome-wide ready correlation gene networks embedded with functional modules and GPMTC genes.
Functional modules were derived by assessing the uncertainty in hierarchical cluster analysis using the dependency data in raw data matrix as well as in the correlation matrix unbiasedly and statistically by multiscale bootstrap resampling with pvclust method for 4 different combinations of clustering schemes by distances and methods. The 21Q1 and 23Q2 versions of DepMap data were used to test the robustness of the revealed functional modules. In the "circular" layout, member genes in each functional module are displayed in each small circular area for the corresponding module in an assigned rainbow color, although other genes such as RAS genes or closely related genes commonly critical in RAS pathway are also included, if not in derived function modules,as colored in gray nodes, which are also organized into small circular area in "circular" layout. All the genes are arranged along the large peripheral circle of the whole network in "circular" layout although other layout styles can be used. The GPMTC genes, which are mutual top correlated genes for each other in each pair of GPMTC genes, are connected with gold-colored lines, with many of the GPMTC genes also as genes of functional modules. Those not belonging to functional modules are displayed as gray-colored nodes.
The lines connecting genes represent correlation levels by thickness of the lines: green for positive and red for negative correlation. Only significant correlation levels will be visible as lines displayed in the network. As mentioned, gold lines connect the GPMTC genes. The default layout of the network is "circular," although you can change to other layout styles with "Layout" options for the same set of genes in the current displayed network.
You can choose to display the default network for a chosen cell type (gene mutation status, e.g., RAS genes, BRAF; tissue types, e.g., Pancreas, Lung, Colon, etc.; RAS dependency status) by selecting from a list of different input cell types/contexts. You can also visualize the relations of the same set of genes in another cell type by choosing a new cell type to be changed on the current network.
The font size of genes in the network and the title of the network can also be changed. You can manipulate the network in many different ways: add your interested genes, if not present, to the currently displayed or default network (note: if genes are not in DepMap datasets, they may not be added, although 17k genes are covered); visualize a subset of the current network; find and add top bridge gene(s) (designated as the top dual correlated gene(s) with the top product(s) of correlation coefficients for both seed genes as the potential bridge gene(s)) for each pair of interested seed genes; delete the gene(s) from the current network; expand the current network by functional modules, GPMTC genes by default, or by top correlated genes (up to top 100, can be increased to more if needed) as defined by you; and undo the previous network manipulation.
You can save the current network into a designated .csv file, which can be used to re-create the network later, as long as you use the same cell type/context. You can also save the image of the current network into an image file for a chosen format.
This tool is dynamic, and you are welcome to approach us (RAS Initiative Bioinformatics Research Team) to potentially get better cell types or contexts that meet your needs. If your interested cell type or context is not available in the current dropdown list of cell types/contexts, you can either choose a closely related cell type in the list or ask if we can create that cell type specifically for your purpose, as long as the DepMap data has enough numbers of the cell lines for that cell type/context. Please first check out the last section at the bottom of this web page as below for more details. Also, if possible, we will create the cell type and context and include it in the list of selectable cell types for customized usage.
Below in the next section, we included a few tutorial videos to help you get started.
In addition, please check out the last section entitled "Useful Information about the Details and Numbers of Cell Lines for Each Cell Type/Context Currently Available in the Tool" at the bottom of this webpage, which not only lists the cell types/contexts available in the tool and related details but also informs whether a corresponding cell type/context has sufficient numbers of cell lines for deriving the gene-gene correlation, function modules and GPMTC genes, since generally the more cell lines available for the cell type/context, the inferred gene-gene relations would be more reliable.
To access the tool, use the following hyperlink: RAS Pathway DepMap Correlation Network Explorer.
The table below lists not only the cell types/contexts available in the tool and and related details, but also the numbers of cell lines from each cell type/context used in the 21Q1 and 23Q2 versions of DepMap data for deriving the correlation networks, which are useful to inform if the corresponding cell type/context has sufficient numbers of cell lines for reliably deriving the correlation, function modules and GPMTC genes. In general, the more cell lines available for the cell type/context, the inferred gene-gene relations would be more reliable.
| Cell Type | Details | Number of Cell Lines in 21Q1 | Number of Cell Lines in 23Q2 |
|---|---|---|---|
| AllBILIARY.TRACTLines | BILIARY TRACT Lines | 30 | 37 |
| AllBLOODLines | HAEMATOPOIETIC AND LYMPHOID TISSUE lines (2nd run) | 95 | 116 |
| AllBRAFV600ELines | BRAF V600E mutant lines | 59 | 69 |
| AllHRASmutLines | HRAS mutant lines | 16 | 17 |
| AllKRASG12C_LungLines | KRAS G12C mutant lung lines | 12 | 12 |
| AllKRASG12CLines | KRAS G12C mutant lines | 18 | 20 |
| AllKRASG12CVDLines | KRAS G12C/V/D mutant lines (any G12 to C/V/D mutant) | 101 | 109 |
| AllKRASG12D_PANCLines | KRAS G12D mutant pancreas lines | 18 | 19 |
| AllKRASG12DLines | KRAS G12D mutant lines | 50 | 52 |
| AllKRASG12V_LungLines | KRAS G12V mutant lung lines | 7 | 7 |
| AllKRASG12V_PANCLines | KRAS G12V mutant pancreas lines | 14 | 15 |
| AllKRASG12VLines | KRAS G12V mutant lines | 33 | 37 |
| AllKRASG12XG13XLines | KRAS G12X/G13X lines (any G12 and/or any G13 mutant) | 137 | 147 |
| AllKRASG12XLines | KRAS G12X lines (any G12 mutant) | 121 | 131 |
| AllKRASG13XLines | KRAS G13X mutant lines (any G13 mutant) | 16 | 16 |
| AllKRASmutBILIARY.TRACT | KRAS mutant BILIARY TRACT lines | 12 | 14 |
| AllKRASmutColonLines | KRAS mutant colon lines | 27 | 30 |
| AllKRASmutKRASengLines | KRAS mutant lines from KRAS-engaged tissue types (Sci Rep. 2024 14(1):25452) | 124 | 136 |
| AllKRASMutLines | KRAS mutant lines | 168 | 181 |
| AllKRASmutLungLines | KRAS mutant lung lines | 36 | 37 |
| AllKRASmutNRASengLines | KRAS mutant lines from NRAS-engaged tissue types (Sci Rep. 2024 14(1):25452) | 11 | 14 |
| AllKRASmutOVARY | KRAS mutant OVARY lines | 9 | 11 |
| AllKRASmutPancLines | KRAS mutant pancreas lines | 40 | 43 |
| AllKRASWTLines | KRAS WT lines | 777 | 906 |
| AllLines | All cell lines | 946 | 1095 |
| AllMelanomaLines | Melanoma lines | 50 | 63 |
| AllNoBRAFV600ELines | Non-BRAFV600E (not mutant on BRAF V600E) lines | 886 | 1026 |
| AllNoMelanomaLines | Not Melanoma lines | 895 | 1032 |
| AllNoRASQ61Lines | Not (H-/N-/K-) RAS Q61 mutant lines | 885 | 1037 |
| AllNRASmutDepLungLines | NRAS mutant NRAS dependent converted lung lines | 4 | 4 |
| AllNRASmutKRASengLines | NRAS mutant lines from KRAS-engaged tissue types (Sci Rep. 2024 14(1):25452) | 8 | 9 |
| AllNRASMutLines | NRAS mutant lines | 62 | 64 |
| AllNRASmutLungLines | NRAS mutant converted lung lines (2 lines maybe depend upon KRAS rather than NRAS by CRISPR scores) | 6 | 6 |
| AllNRASmutNRASengLines | NRAS mutant lines from NRAS-engaged tissue types (Sci Rep. 2024 14(1):25452) | 40 | 41 |
| AllNRASmutSkinLines | NRAS mutant skin lines | 7 | 13 |
| AllNRASWTLines | NRAS WT lines | 883 | 1023 |
| AllOVARY | OVARY lines | 56 | 58 |
| AllRASQ61Lines | (H-/N-/K-) RAS Q61 mutant lines | 60 | 58 |
| AllRASwtCNSLines | (H-/N-/K-) RAS WT CNS lines | 72 | 80 |
| AllRASwtColonLines | (H-/N-/K-) RAS WT colon lines | 24 | 27 |
| AllRASwtKRASengLines | (H-/N-/K-) RAS WT lines from KRAS-engaged tissue types (Sci Rep. 2024 14(1):25452) | 195 | 216 |
| AllRASwtLines | (H-/N-/K-) RAS WT lines | 704 | 826 |
| AllRASwtLungLines | (H-/N-/K-) RAS WT lung lines | 69 | 82 |
| AllRASwtNRASengLines | (H-/N-/K-) RAS WT lines from NRAS-engaged tissue types (Sci Rep. 2024 14(1):25452) | 269 | 305 |
| AllRASwtSkinLines | (H-/N-/K-) RAS WT skin lines | 43 | 49 |
| AllRASwtSoftTissueLines | (H-/N-/K-) RAS WT soft tissue lines | 40 | 47 |
| AUTONOMIC_GANGLIA | AUTONOMIC GANGLIA lines | 32 | 38 |
| BRAFV600EMelanoma | BRAF V600E mutant melanoma lines | 38 | 41 |
| BRAFV600EnonMelanoma | BRAF V600E non-melanoma lines | 21 | 28 |
| BREAST | BREAST lines | 43 | 48 |
| CENTRAL_NERVOUS_SYSTEM | CENTRAL NERVOUS SYSTEM lines | 76 | 81 |
| CNS | CENTRAL NERVOUS SYSTEM lines (2nd run) | 76 | 81 |
| Exp.Sci.Her2.ERBB2.Amp.Fig2B | Expression data rather than DepMap CRISPR data for HER2(ERBB2)-amplified or overexpressing cell lines in Fig 2B of Science paper: Science 389/409-415(2025) | 18 | 18 |
| Exp.Sci.Her2.ERBB2.Amp.sub.Fig2B | Expression data rather than DepMap CRISPR data for subset of HER2(ERBB2)-amplified or overexpressing cell lines in Fig 2B of Science paper: Science 389/409-415(2025) that have a similar curve as in Fig 2A | 12 | 12 |
| Exp.Sci.Her2AmpList.NegShift | Expression data rather than DepMap CRISPR data for subset of HER2(ERBB2)-amplified or overexpressing cell lines in Fig 2B of Science paper: Science 389/409-415(2025) that are union of selected lines from all 4 original HER+ groups with negative shift cutoff (more stringent) over other control groups to make sure each individual cell line with obvious negative shift for each of ERBB2/ EREBB3/ PIK3CA and AKT1 genes | 9 | 9 |
| Exp.Sci.Her2AmpList.NegShift2 | Expression data rather than DepMap CRISPR data for subset of HER2(ERBB2)-amplified or overexpressing cell lines in Fig 2B of Science paper: Science 389/409-415(2025) that are union of selected lines from all 4 original HER+ groups with negative shift cutoffs (less stringent) over other control groups to make sure each individual cell line with obvious negative shift for each of ERBB2/ EREBB3/ PIK3CA and AKT1 genes | 13 | 13 |
| Exp.Sci.Her2AmpList.OverMinCN | Expression data rather than DepMap CRISPR data for DepMap Cell lines whose copy numbers are higher than the mimimal of HER2(ERBB2)-amplified or overexpressing cell lines in Fig 2B of Science paper: Science 389/409-415(2025) | 40 | 43 |
| Exp.Sci.Her2AmpsubsetList.OverMinCN | Expression data rather than DepMap CRISPR data for DepMap Cell lines whose copy numbers are higher than the mimimal of the subset of HER2(ERBB2)-amplified or overexpressing cell lines in Fig 2B of Science paper: Science 389/409-415(2025) that have a similar curve as in Fig 2A | 26 | 28 |
| Exp.Sci.KRASG12Xmut.Fig2D | Expression data rather than DepMap CRISPR data for KRAS G12X mutant cell lines in Fig 2D of Science paper: Science 389/409-415(2025) | 29 | 28 |
| Exp.Sci.KRASG12XmutPIK3CAmut.Fig2A | Expression data rather than DepMap CRISPR data for KRAS G12X mutant cell lines in Fig 2D and PIK3CA mutant cell lines in Fig 2C of Science paper: Science 389/409-415(2025) | 48 | 47 |
| Exp.Sci.KRASmut.Fig2D | Expression data rather than DepMap CRISPR data for KRAS mutant cell lines in Fig 2D of Science paper: Science 389/409-415(2025) | 36 | 36 |
| Exp.Sci.PIK3CAmut.Fig2C | Expression data rather than DepMap CRISPR data for PIK3CA mutant cell lines in Fig 2C of Science paper: Science 389/409-415(2025) | 19 | 19 |
| Exp.Sci.PTENnull | Expression data rather than DepMap CRISPR data for DepMap PTEN damaging mutant cell lines plus PTEN null mutant cell lines in Fig 2A of Science paper: Science 389/409-415(2025) | 95 | 79 |
| HAEMATOPOIETIC_AND_LYMPHOID_TISSUE | HAEMATOPOIETIC AND LYMPHOID TISSUE lines | 95 | 116 |
| HRAS.DepLines | HRAS-dependent lines (with more negative CRISPR scores for HRAS) | 88 | 40 |
| KRAS.DepLines | KRAS-dependent lines(with more negative CRISPR scores for KRAS) | 233 | 269 |
| KRASG12DVCR.TP53DBDMut | Double mutant lines of KRAS G12DVCR (any G12 to D/V/C/R) mutant and TP53 DNA-Binding Domain mutant | 52 | 48 |
| KRASG12DVCR.TP53DBDNonSMut | Double mutant lines of KRAS G12DVCR (any G12 to D/V/C/R) mutant and TP53 DNA-Binding Domain plus Nonsense mutant | 58 | 56 |
| KRASG12DVCR.TP53WT | KRAS G12DVCR (any G12 to D/V/C/R) mutant lines with WT TP53 | 34 | 40 |
| KRASGenMut.TP53DBDMut | Double mutant lines of KRAS mutant and TP53 DNA-Binding Domain plus Nonsense mutant | 83 | 76 |
| KRASGenMut.TP53DBDNonSMut | Double mutant lines of KRAS mutant and TP53 DNA-Binding Domain plus Nonsense mutant | 93 | 88 |
| KRASGenMut.TP53DBDNonSMut.Colon | Double mutant colon lines of KRAS mutant and TP53 DNA-Binding Domain plus Nonsense mutant | 17 | 19 |
| KRASGenMut.TP53DBDNonSMut.LUNG | Double mutant lung lines of KRAS mutant and TP53 DNA-Binding Domain plus Nonsense mutant | 21 | 14 |
| KRASGenMut.TP53DBDNonSMut.Pancreas | Double mutant pancreas lines of KRAS mutant and TP53 DNA-Binding Domain plus Nonsense mutant | 24 | 23 |
| KRASGenMut.TP53NonSMut | Double mutant lines of KRAS mutant and TP53 Nonsense mutant | 10 | 12 |
| KRASGenMut.TP53WT | KRAS mutant lines with WT TP53 | 53 | 60 |
| KRASGenMut.TP53WT.Colon | KRAS mutant colon lines with WT TP53 | 7 | 8 |
| KRASGenMut.TP53WT.LUNG | KRAS mutant lung lines with WT TP53 | 12 | 12 |
| KRASGenMut.TP53WT.Pancreas | KRAS mutant pancreas lines with WT TP53 | 8 | 10 |
| KRASmutBLOOD | KRAS mutant converted blood lines | 8 | 9 |
| LARGE_INTESTINE | Colon lines | 51 | 55 |
| LUNG | LUNG lines | 113 | 124 |
| MRAS.DepLines | MRAS-dependent lines(with more negative CRISPR scores for MRAS) | 91 | 35 |
| NRAS.DepLines | NRAS-dependent lines(with more negative CRISPR scores for NRAS) | 124 | 112 |
| NRASmutBLOOD | NRAS mutant blood lines | 21 | 21 |
| NRASQ61LHP | NRAS Q61L/H/P mutant lines | 10 | 9 |
| NRASQ61Melanoma | NRAS Q61 mutant melanoma lines | 6 | 8 |
| NRASQ61Mut | NRAS Q61 mutant lines | 42 | 39 |
| NRASQ61RK | NRAS Q61R/K mutant lines | 32 | 30 |
| PANCREAS | PANCREAS lines | 43 | 47 |
| RASQ61LHP | (H-/N-/K-) RAS Q61L/H/P mutant lines | 25 | 23 |
| RASQ61Melanoma | (H-/N-/K-) RAS Q61 mutant melanoma lines | 7 | 9 |
| RASQ61RK | (H-/N-/K-) RAS Q61R/K mutant lines | 36 | 35 |
| RASwtBLOOD | (H-/N-/K-) RAS mutant blood lines | 65 | 82 |
| RRAS.DepLines | RRAS-dependent lines(with more negative CRISPR scores for RRAS) | 122 | 59 |
| RRAS2.DepLines | RRAS2-dependent lines(with more negative CRISPR scores for RRAS2) | 40 | 37 |
| Sci.Her2.ERBB2.Amp.Fig2B | HER2(ERBB2)-amplified or overexpressing cell lines in Fig 2B of Science paper: Science 389/409-415(2025) | 13 | 13 |
| Sci.Her2.ERBB2.Amp.sub.Fig2B | subset of HER2(ERBB2)-amplified or overexpressing cell lines in Fig 2B of Science paper: Science 389/409-415(2025) that have a similar curve as in Fig 2A | 8 | 8 |
| Sci.Her2AmpList.NegShift | Subset of HER2(ERBB2)-amplified or overexpressing cell lines in Fig 2B of Science paper: Science 389/409-415(2025) that are union of selected lines from all 4 original HER+ groups with negative shift cutoff (more stringent) over other control groups to make sure each individual cell line with obvious negative shift for each of ERBB2/ EREBB3/ PIK3CA and AKT1 genes | 11 | 11 |
| Sci.Her2AmpList.NegShift2 | Subset of HER2(ERBB2)-amplified or overexpressing cell lines in Fig 2B of Science paper: Science 389/409-415(2025) that are union of selected lines from all 4 original HER+ groups with negative shift cutoffs (less stringent) over other control groups to make sure each individual cell line with obvious negative shift for each of ERBB2/ EREBB3/ PIK3CA and AKT1 genes | 15 | 15 |
| Sci.Her2AmpList.OverMinCN | DepMap Cell lines whose copy numbers are higher than the mimimal of HER2(ERBB2)-amplified or overexpressing cell lines in Fig 2B of Science paper: Science 389/409-415(2025) | 29 | 33 |
| Sci.Her2AmpsubsetList.OverMinCN | DepMap Cell lines whose copy numbers are higher than the mimimal of the subset of HER2(ERBB2)-amplified or overexpressing cell lines in Fig 2B of Science paper: Science 389/409-415(2025) that have a similar curve as in Fig 2A | 18 | 21 |
| Sci.KRASG12Xmut.Fig2D | KRAS G12X mutant cell lines in Fig 2D of Science paper: Science 389/409-415(2025) | 24 | 24 |
| Sci.KRASG12XmutPIK3CAmut.Fig2A | KRAS G12X mutant cell lines in Fig 2D and PIK3CA mutant cell lines in Fig 2C of Science paper: Science 389/409-415(2025) | 40 | 40 |
| Sci.KRASmut.Fig2D | KRAS mutant cell lines in Fig 2D of Science paper: Science 389/409-415(2025) | 30 | 31 |
| Sci.PIK3CAmut.Fig2C | PIK3CA mutant cell lines in Fig 2C of Science paper: Science 389/409-415(2025) | 16 | 16 |
| Sci.PTENnull | DepMap PTEN damaging mutant cell lines plus PTEN null mutant cell lines in Fig 2A of Science paper: Science 389/409-415(2025) | 73 | 66 |
| SKIN | SKIN lines | 54 | 63 |
| SOFT_TISSUE | SOFT TISSUE lines | 46 | 50 |
| STOMACH | STOMACH lines | 33 | 34 |
| URINARY_TRACT | URINARY TRACT lines | 29 | 31 |